| Abstract: | Endothelin-1(ET-1) is the most potent vasoconstrictor agent known. ET-1 is elevatedin the cerebrospinal fluid following hemorrhage and brain injury andcan compromise cerebral microvascular homeostasis. The modulation ofET-1 production by cerebral microvascular endothelial cells and themechanism by which such changes take place are very important in ourunderstanding of the pathological roles of ET-1. In the present study,we investigated the effects of vasoconstrictor agents that can bereleased from hemolyzed blood, cAMP-dependent dilators, and the role ofprotein kinase C (PKC) in the regulation of ET-1 production by pigletcerebral microvascular endothelial cells in culture. ET-1 was measured by RIA. 1) Cerebral microvascularendothelial cells synthesize and release ET-1 into the media;2) 5-hydroxytryptamine (5-HT), lysophosphatidic acid (LPA), thromboxane analog U-46619, fetal bovineserum (20%), and phorbol 12-myristate 13-acetate significantly increase ET-1 production; 3) basaland vasoconstrictor agent-induced increases in ET-1 production byendothelial cells may be mediated via PKC;4) cAMP-dependent vasodilatorsattenuate the basal production of ET-1 by cerebral microvessels; and5) pretreatment of endothelial cellswith a higher concentration of LPA, U-46619, or 5-HT counterbalances the cAMP-dependent dilator agent-induced reduction in basal ET-1 production. Therefore, by-products of hemolyzed blood can stimulate theproduction of ET-1 by a PKC-mediated mechanism. cAMP-dependent dilatorscan attenuate the vasoconstrictor agent-induced elevation in ET-1production. These results suggest that cerebral microvascular homeostasis could be compromised by effects of interactions among vasoactive agents released during conditions injurious to the brain andthey may further the understanding of potential contributions ofhemolyzed blood clots to subarachnoid hemorrhage-induced vasospasm. |
